ADHD. Attention-deficit hyperactivity disorder, combined type
Conditions
Interventions
Intervention 1: Control group: Ritalin, 0.1-3.5 mg per kg of body weight. For the first week, one tablet daily (1.2 tablets at the morning, 1.2 tablets at the noon), and for the second week, one table
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
6 Years to 17 Years
Inclusion criteria
Inclusion criteria: ADHD diagnosis based on DSM5 Children between 6-17 years old.
Exclusion criteria
Exclusion criteria: Presence of severe medical illness, neurological problems and problems requiring surgery Presence of any concomitant psychiatric disorder that requires treatment with psychiatric drugs except ODD History of treatment with ropinirole in the three months prior to the study Consumption neuroleptic medication in the last 6 months Weight less than 13.5 kg Mental retardation Uncontrolled seizure disorder Systolic blood pressure above 125 mm Hg or Resting pulse rate less than 60 beats per minute or above 115 beats per minute Using any medicine or supplement for the treatment of ADHD History of allergy to methylphenidate or ropinirole
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Severity of ADHD. Timepoint: Weeks: 0 , 4 , 8. Method of measurement: By ADHD Rating Scale (by parents or teacher). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Shahin Akhondzadeh
Tehran University of Medical Sciences
Outcome results
None listed